Intelligence Β· Patent portfolio
Nektar Therapeutics UK Patents
Full USPTO pharma patent portfolio for Nektar Therapeutics UK β grant dates, expiration, and drug cross-links.
- Patents
- 423
- Expiring β€24m
- 24
Quick answer
Nektar Therapeutics UK has 423 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 24 expire within 24 months β use filters for patent-cliff planning.
-
US 8227555
Hydrolytically stable maleimide-terminated polymers
granted -
US 8227558
Method for preparing polymer maleimides
granted -
US 8217123
Stabilized polymeric thiol reagents
granted -
US 8193306
Methods for preparing polymeric reagents and compositions of polymeric reagents
granted -
US 8182801
Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
granted -
US 8183338
Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 8173666
Oligomer-opioid agonist conjugates
granted -
US 8143378
Polymer factor VIII moiety conjugates
granted -
US 8133977
Polymer-factor VIII moiety conjugates
granted -
US 8133865
von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
granted -
US 8106131
Hydrolytically stable maleimide-terminated polymers
granted -
US 8097695
Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof
granted -
US 8088365
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
granted -
US 8084572
Segmented polymers and their conjugates
granted -
US 8080236
Particulate materials
granted -
US 8076412
Water-soluble polymer alkanals
granted -
US 8071692
Multi-arm block copolymers as drug delivery vehicles
granted -
US 8071678
Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
granted -
US 8067505
Method of preparing carboxylic acid functionalized polymers
granted -
US 8067431
Chemically modified small molecules
granted -
US 8058385
Method for preparing conjugates using polymer maleimides
granted -
US 8039579
Intermediates useful in the preparation of maleimide functionalized polymers
granted -
US 8034825
Chemically modified small molecules
granted -
US 8008435
Polymer stabilized neuropeptides
granted -
US 8003742
Polymer derivatives with proximal reactive groups
granted -
US 7994272
Maleamic acid polymer derivatives and their bioconjugates
granted -
US 7988956
Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
granted -
US 7976834
Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles
granted -
US 7977427
Method involving 1-benzotriazolyl carbonate esters of polymers
granted -
US 7964217
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
granted -
US 7960502
Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
granted -
US 7947261
Conjugates formed from polymer derivatives having particular atom arrangements
granted -
US 7910661
Thiol-selective water-soluble polymer derivatives
granted -
US 7887789
Polymer derivatives having particular atom arrangements
granted -
US 7872072
Branched polymers and their conjugates
granted -
US 7872082
Method for preparing polymer maleimides
granted -
US 7863421
Polymer-factor VIII moiety conjugates
granted -
US 7858749
Polymer-factor VIII moiety conjugates
granted -
US 7851565
Stabilized polymeric thiol reagents
granted -
US 7838595
Water-soluble polymer alkanals
granted -
US 7834088
Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
granted -
US 7834138
Segmented polymers and their conjugates
granted -
US 7829074
Hydroxypatite-targeting poly(ethylene glycol) and related polymers
granted -
US 7790835
Method of preparing maleimide functionalized polymers
granted -
US 7786221
Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules
granted -
US 7786133
Chemically modified small molecules
granted -
US 7767784
Methods for preparing polymeric reagents and compositions of polymeric reagents
granted -
US 7744861
Multi-arm polymer prodrugs
granted
Frequently asked questions
How many patents does Nektar Therapeutics UK have?
423 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Nektar Therapeutics UK patents expire?
24 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory